Dallah Healthcare Company (4004.SR)
SAR 120.6
(-1.15%)
SAR 120.6
(-1.15%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.77 Billion SAR | 3.05% |
| 2022 | 2.68 Billion SAR | 5.46% |
| 2021 | 2.54 Billion SAR | 19.25% |
| 2020 | 2.13 Billion SAR | 53.34% |
| 2019 | 1.39 Billion SAR | 27.13% |
| 2018 | 1.09 Billion SAR | 31.15% |
| 2017 | 836.08 Million SAR | 13.23% |
| 2016 | 738.4 Million SAR | 21.52% |
| 2015 | 607.62 Million SAR | 52.29% |
| 2014 | 398.98 Million SAR | 38.21% |
| 2013 | 288.67 Million SAR | 83.68% |
| 2012 | 157.16 Million SAR | -31.34% |
| 2011 | 228.9 Million SAR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.76 Billion SAR | 3.2% |
| 2024 Q1 | 2.67 Billion SAR | -3.36% |
| 2023 Q4 | 2.77 Billion SAR | 4.52% |
| 2023 FY | 2.77 Billion SAR | 3.05% |
| 2023 Q3 | 2.65 Billion SAR | -2.18% |
| 2023 Q1 | 2.67 Billion SAR | -0.43% |
| 2023 Q2 | 2.7 Billion SAR | 1.23% |
| 2022 Q4 | 2.68 Billion SAR | -4.53% |
| 2022 Q1 | 2.55 Billion SAR | 0.13% |
| 2022 Q3 | 2.81 Billion SAR | 11.85% |
| 2022 FY | 2.68 Billion SAR | 5.46% |
| 2022 Q2 | 2.51 Billion SAR | -1.37% |
| 2021 Q3 | 2.25 Billion SAR | 5.12% |
| 2021 Q1 | 2.14 Billion SAR | 0.2% |
| 2021 FY | 2.54 Billion SAR | 19.25% |
| 2021 Q2 | 2.14 Billion SAR | 0.02% |
| 2021 Q4 | 2.54 Billion SAR | 13.2% |
| 2020 Q1 | 1.57 Billion SAR | 12.85% |
| 2020 Q2 | 1.5 Billion SAR | -4.38% |
| 2020 Q3 | 1.55 Billion SAR | 3.41% |
| 2020 FY | 2.13 Billion SAR | 53.34% |
| 2020 Q4 | 2.13 Billion SAR | 37.42% |
| 2019 Q2 | 1.38 Billion SAR | 21.15% |
| 2019 FY | 1.39 Billion SAR | 27.13% |
| 2019 Q4 | 1.39 Billion SAR | 3.84% |
| 2019 Q3 | 1.34 Billion SAR | -3.4% |
| 2019 Q1 | 1.14 Billion SAR | 4.61% |
| 2018 Q1 | 813.58 Million SAR | -2.69% |
| 2018 FY | 1.09 Billion SAR | 31.15% |
| 2018 Q4 | 1.09 Billion SAR | 8.61% |
| 2018 Q3 | 1 Billion SAR | 3.67% |
| 2018 Q2 | 973.88 Million SAR | 19.7% |
| 2017 Q3 | 727.73 Million SAR | 1.48% |
| 2017 Q1 | 633.49 Million SAR | -14.21% |
| 2017 Q4 | 836.08 Million SAR | 14.89% |
| 2017 FY | 836.08 Million SAR | 13.23% |
| 2017 Q2 | 717.1 Million SAR | 13.2% |
| 2016 Q3 | 696.23 Million SAR | 3.5% |
| 2016 FY | 738.4 Million SAR | 21.52% |
| 2016 Q2 | 672.66 Million SAR | 5.85% |
| 2016 Q1 | 635.47 Million SAR | 4.58% |
| 2016 Q4 | 738.4 Million SAR | 6.06% |
| 2015 Q3 | 543.91 Million SAR | -5.94% |
| 2015 Q4 | 607.62 Million SAR | 11.71% |
| 2015 FY | 607.62 Million SAR | 52.29% |
| 2015 Q1 | 547.68 Million SAR | 37.27% |
| 2015 Q2 | 578.26 Million SAR | 5.58% |
| 2014 Q2 | 307.82 Million SAR | 16.16% |
| 2014 FY | 398.98 Million SAR | 38.21% |
| 2014 Q1 | 265 Million SAR | -8.2% |
| 2014 Q3 | 384.84 Million SAR | 25.02% |
| 2014 Q4 | 398.98 Million SAR | 3.67% |
| 2013 Q1 | 199.47 Million SAR | 26.93% |
| 2013 Q2 | 178.01 Million SAR | -10.76% |
| 2013 Q3 | 207.18 Million SAR | 16.38% |
| 2013 FY | 288.67 Million SAR | 83.68% |
| 2013 Q4 | 288.67 Million SAR | 39.33% |
| 2012 FY | 157.16 Million SAR | -31.34% |
| 2012 Q4 | 157.16 Million SAR | -21.31% |
| 2012 Q3 | 199.71 Million SAR | 0.0% |
| 2011 FY | 228.9 Million SAR | 0.0% |
| 2011 Q4 | 228.9 Million SAR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Mouwasat Medical Services Company | 1.53 Billion SAR | -80.152% |
| National Medical Care Company | 760.92 Million SAR | -264.056% |
| Al Hammadi Company For Development and Investment | 749.52 Million SAR | -269.595% |
| Middle East Healthcare Company | 3.59 Billion SAR | 23.028% |
| Dr. Sulaiman Al Habib Medical Services Group Company | 8.97 Billion SAR | 69.142% |
| Canadian General Medical Center Complex Company | 22.28 Million SAR | -12330.311% |
| Arabian International Healthcare Holding Company | 1.04 Billion SAR | -165.86% |
| Future Care Trading Co. | 10.49 Million SAR | -26295.477% |
| Naba Alsaha Medical Services Company | 96.62 Million SAR | -2767.0% |
| Lana Medical Co. | 26.45 Million SAR | -10371.981% |
| Al-Modawat Specialized Medical Co. | 39.76 Million SAR | -6865.717% |